A personalised mRNA cancer vaccine has produced positive results in a final-stage trial involving skin cancer, raising hopes for the approach, discovers Michael Le Page BECAUSE every cancer is different, researchers have for decades been working on personalised cancer vaccines designed to make the immune system recognise and attack cancers specific to each individual. The results have been mixed, but now a personalised cancer vaccine has produced positive results in a final-stage, or phase III, trial for the first time. …
摘自《新科学家》(New Scientist)第271卷 第3610期 · 2026年8月29日,Michael Le Page。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。